Interestingly, patients (16) in which heparanase staining between primary tumor and metastasis was changed exhibited worse prognosis vs patients exhibiting stable heparanase pattern (HR 0.035; p = 0.005) (Figure 1B). This evidence concerns the gene HPSE and neoplasm.